News
After 23 goals and 24 assists in 142 appearances across all competitions for Bayer Leverkusen during a four year spell, Amine ...
After securing Ernest Poku’s transfer, Bayer Leverkusen are continuously looking to strengthen their squad for the 2025/26 ...
Jarrel Quansah’s move to Bayer Leverkusen removed what little cover Arne Slot had for this position. Virgil van Dijk and Ibrahima Konaté form a formidable first-choice pairing, but the injury-prone ...
Bayer will partner with Kumquat Biosciences to develop Kumquat’s KRAS G12D inhibitor, which could generate $1.3 billion-plus for the San Diego biotech.
The Alexander Isak continues to play out with the Newcastle star making it clear he wants out as Liverpool wait in the wings as Manchester United continue to plot a move for Carlos Baleba ...
After securing Ernest Poku’s transfer, Bayer Leverkusen are continuously looking to strengthen their squad for the 2025/26 ...
Bayer partners with Kumquat Biosciences to advance a promising Kras G12D cancer treatment, aiming to address critical unmet ...
Liverpool have opened talks with Crystal Palace over a move for England star Marc Guehi, with their Premier League rivals ...
In this instance, the comparison between Garnacho and Rodrygo stems from FBref, which analysed players in similar positions in the 23/24 Champions League season and concluded that the Real Madrid star ...
Kumquat, based in San Diego, received US Food and Drug Administration clearance of its investigational new drug application for the KRAS G12D inhibitor in July. The firm will be responsible for ...
Cristiano Ronaldo demanded a contract clause to return to Manchester United in 2021 and it's one that could cost Chelsea in the future ...
The German pharma will license a KRAS G12D inhibitor from Kumquat Biosciences. Elsewhere, a Biohaven OCD drug missed its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results